期刊文献+

缬沙坦对心力衰竭幼鼠心功能及肌浆网Ca^(2+)-ATP酶活性的影响 被引量:3

Effect of valsartan on heart function and activity of myocardial sarc-oplasmic reticulum Ca^(2+)-ATPase in junior rat with heart failure
下载PDF
导出
摘要 目的:研究缬沙坦对心力衰竭(Heart failure,HF)(简称心衰)幼鼠心功能及肌浆网(Sarcoplasmic reticulum,SR)Ca2+-ATP酶(Ca2+-ATPase,SERCA2a)活性和Ca2+重吸收量的影响。方法:采用腹主动脉-下腔静脉造瘘术建立幼鼠心衰模型,术后8周随机分为2组:心衰组和缬沙坦治疗组,另设假手术组;缬沙坦灌胃给药,每日观察幼鼠的呼吸、皮毛颜色、活动量等发育情况;术后12周高频超声检测心功能;定磷法测定SR膜SERCA2a酶活性;荧光分光光度仪检测钙离子(Ca2+)的重吸收量。结果:与假手术组(n=15)比较,对照组(n=20)幼鼠左室舒张末期内径(LVIDd)、左室收缩末期内径(LVIDs)、左室舒张末期容积(LVEDV)、左室收缩末期容积(LVESV)均明显升高(P<0.01),左室射血分数(EF)、左室短轴缩短率(FS)均明显降低(P<0.01);与对照组比较,缬沙坦治疗组(n=15),LVIDd、LVIDs、LVEDV、LVESV均明显降低(P<0.01),FS、EF升高(P<0.01);对照组的SERCA2a活性较假手术组明显降低(P<0.01),而经缬沙坦治疗后,酶活性接近假手术组(P>0.05);若分别向含有3组SR的缓冲液加入0.5mmol/L ATP后,对照组的Ca2+的重吸收量同假手术组比较,明显降低(P<0.01),与对照组比较,缬沙坦组Ca2+的重吸收量显著提高(P<0.01)。结论:对照组幼鼠心功能显著降低,心肌细胞SERCA2a活性降低,Ca2+重拾量减少,缬沙坦可提高SERCA2a的Ca2+重拾能力,改善细胞收缩、舒张功能,进一步提高心脏功能并有效抑制心室重塑。 Objective: To explore the effect of Valsartan on heart function and a-ctivity of myocardial sarcoplasmic reticulum Ca^2+ ATPase in junior rat with heart failure(HF). Methods: The animal model of congestive heart failure was established byiistulation of abdominal aorta and inferior vena cava.Rats were randomly divided into 2 groups after 8 weeks of operation:rats without treatment as control group(n=20),rats treated with Yalsartan as valsartan group(n=15).Sham-operated was taken as normal control group(n=15).Valsartan was adminis-tered through direct gastric gavage. The high frequency ultrasound was performed 4 weeks after treatment.Myocardial SR was fractionated with velocity centrifugation. Enzyme activity of SERCA2a in SR was detected with ultraviolet spectrophotometre(U V).The time course of Ca^2+ uptake was determined by fluorescent spectrophotometry. Results: Compared with the sham-operated group,left ventricular internal dimension diastole(LVIDd),left ventricularinternal dimension systole (LVIDs),left ventricular end-diastolic volume(LVEDV ), and left ventricular end-systolic volume (LVESV) were all significantly increased(P〈0.01 ),while left ventricular ejection fraction(LVEF),and left ventricular fractional shortening(LVFS)were decreased(P〈0.01 ) in control group.LVIDd,LVIDs,LVEDV,LVESV were all prominently decresed(P〈0.01 ), while LVEF,and LVFS were inreased(P〈0.01 ) in Valsartan group when compared with control group. Enzyme activity of SERCA2a decreased in control group as compared with other two groups. After adding ATP to the buffer including SR of three groups,Ca^2+ uptake was significantly decreased(P〈0.01 ) in control group,and it increased almost to normal level in Valsartan group. Conclusion: Heart function and the enzyme activity of SERCA2a decreased in junior rat with heart failure,Valsartan can anastate the uptake of Ca^2+ by increasing enzyme activity of SERCA2a,and improve cardiac contractility and finally heart function in junior rat with heart failure.
出处 《重庆医科大学学报》 CAS CSCD 2008年第12期1450-1453,共4页 Journal of Chongqing Medical University
基金 重庆市自然科学基金计划项目(CSTC 2005BB5037)
关键词 缬沙坦 心力衰竭 心功能 CA^2+-ATP酶 Valsartan Heart failure Heart function Ca^2+-ATPase
  • 相关文献

参考文献10

  • 1Braz J,Greqory K,Pathak A,et al. PKC-alpha regulates cardiac contractility and propensily toward heart failure[J]. Nat.Med,2004,10: 248-254.
  • 2Marx SO,Reiken S,Hisamatsu Y,et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel(ryanodinge receptor ) :defective regulation in failing hearts[J]. Cell,2000,101: 365-376.
  • 3朱彤莹,黄国英,顾勇,林善锬.两种心衰模型大鼠心功能的比较[J].中国实验动物学报,2002,10(1):51-53. 被引量:20
  • 4李洪林,刘凡,许家素.螺旋内脂与缬沙坦治疗慢性心力衰竭的对照研究[J].重庆医学,2006,35(16):1497-1498. 被引量:2
  • 5袁小媚,马康华.卡托普利和缬沙坦对大鼠心肌梗死后胶原网络重塑的干预研究[J].重庆医学,2006,35(15):1375-1377. 被引量:6
  • 6Yano M,Kobayashi S,Kohno M,et al. FKBPI2.6-mediated stabilization of calcium-release channel (ryanodine receptor)as a novel therapeutic strategy against heart failure[J]. Cir,2003,107:477-484.
  • 7Coughtrie M W,Blair J N,Hume R,et al.Improved preparation of hepatic microsomes for in vitro diagnosis of inherited disorders of the glucose-6-phosphatase system[J]. Clin Chem,1991,37(5):739-742.
  • 8Masafumi Y,Yasuhiro l,Masunori M,et al. Altered intracellular Ca^2+ handling in heartfailure[J].Clin Invest,2005,115:556-564.
  • 9Mori T,Hayashi T,Sohmiya K,et al. Mechanisms of combined treatment with celiprolol and candesartan for ventricutar remodeling in experimental heart failure[J]. Cir,2005,69:596-602.
  • 10Bruckschlegel G,Holmer S R,Jandeleit K,et al. Effect of aldosterone receptor antagonist and angiotenisin Ⅱ type Ⅰ receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction[J]. Circulation,2004,68:376-382.

二级参考文献30

  • 1柴晓利,龙先瑜.卡托普利和缬沙坦联合治疗充血性心力衰竭的临床观察[J].中国医师杂志,2005,7(9):1288-1289. 被引量:1
  • 2梁维基,冼洪光,陈镭.螺内酯对慢性心力衰竭患者神经体液及左心室功能的影响[J].中国医师杂志,2005,7(9):1289-1290. 被引量:8
  • 3[1]Guyatt GH,Sullivan MJ,Thompson PJ,et al.The 6-minute walk:a new measure of exercise capacity in patients with chronic heart failure[J].Can Med Assoc,1985,32(8):919
  • 4[2]Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure[J].N Engl J Med,2001,344:1651
  • 5[7]Yee KM,Pringle SD,Struthers AD.Circadian variation in the effects of aldosterone blockade on heart rate variabibity and QT dispersion in congestive heart failure[J].J Am Cardiol,2001,37:1800
  • 6[8]Pitt B,Zannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure.Randomized aldactone evaluation study investigators[J].N Engl J Med,1999,34:709
  • 7赵林风 李永玲.安体舒通治疗慢性难治性心衰10例疗效观察[J].临床荟萃,2001,5(16):218-218.
  • 8Garcia R, Diebold S,Simple,rapid,and effective method of producing aortocaval shunts in the rat.Cardiovascular Research,1990,24:430-432
  • 9Ding-Li Xu,Pierre-Yves M,Mamiko O,et al.Upregulation of Aquaporin-2 water channel expression in chronic heart failure rat.J Clin Invest,1997,99(7):1500-1505
  • 10Soren N,James T,Ditte A,et al.Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct.Proc Natl Acad Sci U S A,1997,94:5450-5455

共引文献25

同被引文献23

  • 1李小鹰.肌浆网钙ATP酶2a基因转导治疗心力衰竭的研究[J].中华心血管病杂志,2005,33(6):576-578. 被引量:12
  • 2Runikhian NK, Tkacheva ON. Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension[J]. Kardiologiia, 2008,48 ( 9 ) : 50-52.
  • 3Weir MR,Crkielair N,Levy D,et al. Evaluation of the dose response with valsartan and val sartan/hydrochlorothiazide in patients with essential hypertension[J]. J Clin Hypertens,2007,9(2):103-112.
  • 4Barehmann J,Ansari A,Mahla G,et al.Effective and safe reduction of blood pressure with tile combination of amlodipine 5mg and valsartan 160mg in hypertensive patients not controlled by calcium channel blocker monotherapy[J]. Adv Ther, 2008,25 (5) : 399-411.
  • 5尹建明.非洛地平与卡托普利联用治疗原发性高血压临床观察[J].中国现代医生,2007,45(09S):61-61. 被引量:4
  • 6孙传岐,刘跃文,梅春.施慧达治疗轻、中度高血压病71例临床观察[J].山东医药,2007,47(27):164-164. 被引量:5
  • 7Ikeda Y,Hoshijima M,Chien K R.Toward biologically targeted ther-apy of calcium cycling defects in heart failure[J].Physiology(Bethesda),2008,23:6-16.
  • 8Couchonnal LF,Anderson M E.The role of calmodulin kinase II inmyocardial physiology and disease[J].Physiology(Bethesda),2008,23:151-159.
  • 9Anderson M E.CaMK II and a failing strategy for growth in heart[J].J Clin Invest,2009,119(5):1082-1085.
  • 10Zhang T,Maier L S,Dalton N D,et al.The SC isoform of CaMK II isactivated in cardiac hypertrophy and induces dilated cardiomyopathyand heart failure[J],Circ Res,2003,92(8):912-919.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部